InvestorsHub Logo
Followers 11
Posts 2057
Boards Moderated 0
Alias Born 10/26/2012

Re: Carjockey2 post# 15339

Tuesday, 09/26/2023 11:15:42 AM

Tuesday, September 26, 2023 11:15:42 AM

Post# of 21132
Just received this email from the company CEO...

at 10:06 am..

We thank you for being a shareholder and for caring about the health and welfare of BioAdaptives. Our interests are similar to yours.
As a fully-reporting public OTC company, as you surely know, we have very specific obligations to the public and to the SEC, as well as to Company insiders, for timely reporting of material events. As such, we recently filed our 2nd quarter 2023 Form 10-Q as required by the SEC as the period's general update regarding Company activity and status. It is available on-line for all to review. We also file SEC 8-K's when a significant event or change occurs for the public to be advised. Other SEC forms are filed as required, and all are posted on-line for anyone to review.
We are required to keep everyone equally informed regarding Company events. No one gets special reporting or information. As such, we issue press releases through public media for all to see when any significant event or Company change occurs. However, we must be cautious not to make up news, but to timely report it once it occurs.
BioAdaptives is aware of our stockholder support. We have over 13,000 owners of the Company and we want each one, as well as the public, to be as informed as possible. We take that very seriously, and, again, we thank you for your interest and concern and participation.
Please feel free to pass along your thoughts at any time. We appreciate it.

Respectfully,
Bob Ellis, President
BioAdaptives, Inc.
Las Vegas, Nevada USA
rwe@bioadaptives.com
Bullish
Bullish